2026/05/10 Alnylam Pharmaceuticals (ALNY): New Cardiomyopathy Drug & RNAi Technology Platform
The recent broad-based sell-off and multi-year lows in the U.S. Healthcare Sector require a critical assessment of whether there are systemic headwinds over the next three years. Having been deeply influenced by China's Volume-Based Procurement (VBP) over the past three years—where aggressive